Amrize (NYSE:AMRZ) Posts Quarterly Earnings Results, Misses Estimates By $0.04 EPS

Amrize (NYSE:AMRZ) released its quarterly earnings results on Thursday. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04), FiscalAI reports. Amrize had a return on equity of 9.84% and a net margin of 9.70%.

Amrize Trading Down 3.1%

Shares of AMRZ traded down $1.65 during mid-day trading on Thursday, hitting $51.23. 4,587,334 shares of the company’s stock traded hands, compared to its average volume of 3,139,739. The company has a quick ratio of 0.89, a current ratio of 1.40 and a debt-to-equity ratio of 0.38. The firm has a market capitalization of $28.33 billion, a P/E ratio of 24.51, a PEG ratio of 1.09 and a beta of 0.11. The business’s 50-day moving average price is $52.13 and its 200-day moving average price is $54.80. Amrize has a 1 year low of $44.12 and a 1 year high of $65.94.

Amrize Cuts Dividend

The firm also recently declared a dividend, which was paid on Wednesday, May 20th. Investors of record on Tuesday, May 12th were issued a dividend of $0.11 per share. The ex-dividend date was Tuesday, May 12th. Amrize’s payout ratio is currently 21.05%.

Wall Street Analyst Weigh In

A number of brokerages have weighed in on AMRZ. Citigroup decreased their target price on Amrize from $76.00 to $66.00 and set a “buy” rating on the stock in a research note on Monday, May 4th. Oppenheimer cut their price objective on Amrize from $68.00 to $65.00 and set an “outperform” rating for the company in a report on Tuesday, July 21st. Royal Bank Of Canada cut their price objective on Amrize from $61.00 to $60.00 and set a “sector perform” rating for the company in a report on Friday, May 1st. Weiss Ratings downgraded shares of Amrize from a “hold (c-)” rating to a “sell (d+)” rating in a research note on Friday, July 31st. Finally, Vertical Research upgraded shares of Amrize from a “hold” rating to a “buy” rating and set a $70.00 target price for the company in a research report on Friday, May 1st. One investment analyst has rated the stock with a Strong Buy rating, nine have issued a Buy rating, six have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, Amrize has a consensus rating of “Moderate Buy” and a consensus price target of $62.79.

Insider Activity at Amrize

In other Amrize news, CEO Jan Philipp Jenisch purchased 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, May 19th. The stock was bought at an average cost of $49.96 per share, for a total transaction of $149,880.00. Following the purchase, the chief executive officer directly owned 515,000 shares in the company, valued at $25,729,400. The trade was a 0.59% increase in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Mario Gross purchased 1,200 shares of the stock in a transaction that occurred on Wednesday, May 20th. The shares were acquired at an average cost of $48.63 per share, with a total value of $58,356.00. Following the completion of the transaction, the insider owned 34,747 shares in the company, valued at $1,689,746.61. This trade represents a 3.58% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. In the last 90 days, insiders bought 54,918 shares of company stock valued at $2,717,324. 0.54% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On Amrize

A number of institutional investors and hedge funds have recently made changes to their positions in the business. Norges Bank purchased a new stake in shares of Amrize in the fourth quarter worth $929,333,000. Harris Associates L P bought a new position in Amrize in the 4th quarter worth about $615,406,000. Wellington Management Group LLP boosted its stake in Amrize by 48.8% in the 3rd quarter. Wellington Management Group LLP now owns 11,622,024 shares of the company’s stock worth $561,018,000 after purchasing an additional 3,809,133 shares in the last quarter. Marshall Wace LLP grew its position in Amrize by 865.4% during the 3rd quarter. Marshall Wace LLP now owns 2,889,660 shares of the company’s stock valued at $139,436,000 after purchasing an additional 2,590,336 shares during the last quarter. Finally, Barclays PLC raised its holdings in Amrize by 95.4% in the fourth quarter. Barclays PLC now owns 4,614,593 shares of the company’s stock worth $249,557,000 after buying an additional 2,253,431 shares during the last quarter.

About Amrize

Amrize AG focuses on building materials business in North America. The company was incorporated in 2023 and is based in Zug, Switzerland. Amrize AG operates independently of Holcim AG as of June 23, 2025.